JENKEN BIOSCIENCES
Jenken Biosciences is a specialty pharmaceutical company dedicated to the development and commercialization of first-in-class small molecules as TLR4 antagonists. TLR4 (Toll-Like Receptor 4) is a transmembrane protein, a key mediator of inflammatory responses, and a member of TLR family which are mainstays of the innate immune system. Recently, TLR4 has attracted considerable clinical attention and is the subject of a number of published studies on inflammation associated with chronic liver dise... ase, inflammatory bowel disease, cancer, and diabetes, as well as organ damage to the kidney and lung. The Company's drug development strategy is to reduce time-to-market and to lower risk and development costs by re-profiling approved drugs. In addition, the company is developing a rich pipeline of novel chemical entities (NCEs) for therapies of chronic liver disease, inflammatory bowel disease, rheumatoid arthritis, and diabetes, as well as organ damage to the kidney and the lung.
JENKEN BIOSCIENCES
Industry:
Biotechnology Medical
Founded:
2003-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.jenkenbio.com
Total Employee:
1+
Status:
Active
Contact:
919-765-0032
Email Addresses:
[email protected]
Total Funding:
142.72 K USD
Technology used in webpage:
DigiCert SSL Yahoo DNS Yahoo Image CDN Yahoo Yahoo! Business Email
Similar Organizations
Sanare Bioscience
Sanare Bioscience specializes in the development and commercialization of medical products that improve patient outcomes.
Investors List
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Funding Round - Jenken Biosciences
Official Site Inspections
http://www.jenkenbio.com
- Host name: jenkenbio.com
- IP address: 107.6.186.214
- Location: Amsterdam Netherlands
- Latitude: 52.2832
- Longitude: 4.7521
- Timezone: Europe/Amsterdam
- Postal: 1119